References
- Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981;304:989–94.
- Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE. Donor transaminase and recipient hepatitis: impact on blood transfusion services. JAMA 1981;246:630–4.
- Alter HJ, Hoofnagle JH. Non-A, non-B: observations on the first decade. In: Vyas GN, DienstagJL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Orlando, FL: Grune and Stratton, 1984:345–54.
- International Forum. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of posttransfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter? Vox Sang 1983;44:48–64.
- Kahn RA. Reducing hepatitis by testing blood for alanine aminotransferase (letter). N Engl J Med 1983;308:844–5.
- Cuccherini B, Nussbaum SJ, Seeff LB, Lucas L. Zimmerman HJ. Stability of aspartate aminotransferase and alanine aminotransferase activities. J Lab Clin Med 1983;102:370–6.
- Williams KM, Williams AE, Kline LM, Dodd RY. Stability of serum alanine aminotransferase activity. Transfusion 1987;27:431–3.
- Abraham CV, Bakerman S. Isolation and purification of the Rho(D) blood group receptor component from human erythrocyte membrane. Clin Chim Acta 1975;60:33–43.
- Anstee DJ. Blood group MNSs-active sialoglycoproteins of the human erythrocyte membrane. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of the erythrocyte. New York: Alan R Liss, 1980:67–98.
- Anstee DJ. The blood group MNSs-active sialoglycoproteins. Semin Hematol 1981;18:13–31.
- Anstee DJ, Mawby WJ, Parsons SF, Tanner MJA, Giles CM. A novel hybrid sialoglycoprotein in Sta positive human erythrocytes. J Immunogenet 1982;9:51–5.
- Anstee DJ, Mawby WJ, Tanner MJA. Abnormal blood group Ss-active sialogylcoproteins in the membrane of Miltenberger class III, IV and V human erythrocytes. BiochemJ 1979;l83:193-203.
- Anstee DJ, Ridgwell K, Tanner MJA, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins β and γ. Biochem J 1984;221:97–105.
- Baranowski T, Lisowska E, Morawiecki A, Romanowska E, Strozecka K. Studies on blood group antigens M and N. III. Chemical composition of purified antigens. Arch Immunol i Terapii Dosw 1959;7:15–27.
- Basu MK, Flamm M, Schachter D, Bertles JF, Maniatis A. Effects of modulating erythrocyte membrane cholesterol on Rho(D) antigen expression. Biochem Biophys Res Comm 1980;95;87–93.
- Blanchard D, Capon C, Leroy Y, Cartron JP, Fournet B. Comparative study of glycophorin A derived O-glycans from human Cad, Sd(a+) and Sd(a−) erythrocytes. Biochem J 1985;232:813–8.
- Blanchard D, Cartron JP, Fournet B, Montreuil J, van Halbeek H, Vliegenthart JFG. Primary structure of the oligosaccharide determinant of blood group Cad specificity. J Biol Chem 1983; 258:7691–5
- Blanchard D, Dahr W, Cartron JP. Structural analysis of a blood group-Stones active hybrid sialoglycoprotein from human red cell membranes (abstract). Biol Chem Hoppe-Seyler 1985; 366:766.
- Blanchard D, Piller E, Gillard B, Marcus D, Cartron JP. Identification of a novel ganglioside on erythrocytes with blood group Cad specificity. J Biol Chem 1985;260:7813–6.
- Brown PJ, Evans JP, Sinor LT, Tilzer LL, Plapp FV. The Rhesus D antigen is a dicyclohexylcarbodiimide binding proteolipid. Am J Pathol 1983;110:127–34.
- Cartron JP, Blanchard D. Association of human erythrocyte membrane glycoproteins with blood-group Cad specificity. Biochem J 1982;207:497–504.
- Childs RA, Feizi T, Fukuka M, et al. Blood group